Risperidone Microspheres
Brand name: Risperdal Consta
Rank #213 of 500 drugs by total cost
$64.8M
Total Cost
47,567
Total Claims
$64.8M
Total Cost
1,888
Prescribers
$1,362
Cost per Claim
234
Beneficiaries
47,683
30-Day Fills
$34K
Avg Cost/Provider
25
Avg Claims/Provider
About Risperidone Microspheres
Risperidone Microspheres (sold as Risperdal Consta) was prescribed 47,567 times by 1,888 Medicare Part D providers in 2023, costing the program $64.8M. At $1,362 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 210 | Esomeprazole Magnesium (Esomeprazole Magnesium) | $66.3M | 964,193 |
| 211 | Dabigatran Etexilate Mesylate (Dabigatran Etexilate) | $66.0M | 220,652 |
| 212 | Netarsudil Mesylate (Rhopressa) | $65.6M | 129,116 |
| 213 | Risperidone Microspheres (Risperdal Consta) | $64.8M | 47,567 |
| 214 | Venlafaxine Hcl (Venlafaxine Hcl) | $64.7M | 2,187,710 |
| 215 | Canagliflozin (Invokana) | $63.7M | 66,550 |
| 216 | Belimumab (Benlysta) | $63.4M | 13,386 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology